PET Imaging

Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

What's the purpose of the trial?

This phase I trial tests the safety of \[89Zr\]DFO-YS5 positron emission tomography (PET) imaging and how well it works to detect CD46 positive cancer cells in patients with multiple myeloma.

Trial status

Accepting patients

Phase
Phase 1
Enrollment
20
Last Updated
4 months ago
Am I Eligible

Participating Centers

There is one center participating in this trial. Enter a location below to view the distance.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Zirconium Zr 89-DFO-YS5

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Accepting patients

[89Zr]DFO-YS5: Single Scan

Accepting patients

[89Zr]DFO-YS5: Multiple Scans

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.